The Prostagram trial investigated the use of MRI scans to detect prostate cancer. At present, there is no nationally approved…
Could drug treatment combined with targeted radiotherapy improve brain mets prognosis?
'Patients with brain metastases are an underserved population Brain metastases occur in 20-40% of all patients with cancer. Brain metastases…
Working with patients and carers to answer questions in a rare cancer
'Upper tract urothelial cancer is a rare type of cancer that starts in the lining of the urinary tract and…
Improving survival in women with poor-prognosis ovarian cancer
'Around 7,500 women are diagnosed with ovarian cancer in the UK each year. This makes ovarian cancer the 6th most…
Two trials for brain metastases developed following Brain Metastases Workshop
'Brain metastases occur when cancer cells spread from their original site to the brain. Any cancer can spread to the…
Quick and efficient testing of prostate cancer treatments, changing trial design and clinical practice
'Lack of treatments and evidence As recently as ten years ago, despite many new drugs being approved for use in…
Reducing the number of prostate biopsies by improving diagnosis
'Addressing problems with prostate cancer diagnosis To diagnose prostate cancer, PSA (prostate specific antigen) levels in the blood are used…
Reducing the prostate cancer treatment burden on both patients and the health service
'Radiotherapy treatment for prostate cancer Standard radiotherapy for prostate cancer is an important and effective treatment, but until recently involved…
Dramatically reducing the need for surgery in head and neck cancer
'Surgery as the standard of care to monitor head and neck cancer The PET-NECK study set out to investigate if…
Accelerating the pace of neuroblastoma research through collaboration
'A rare childhood cancer Neuroblastoma, a rare children’s cancer, has a particularly low survival rate. Because its incidence is low,…
The SMALL study for treating early-stage breast cancer
'The SMALL study is a phase 3 clinical trial, receiving over £2.3M in funding from the NIHR HTA, designed to…
Investigating kinder treatments in head and neck cancer
'PATHOS is a trial investigating kinder treatments for head and neck cancer patients. It looks at treatment after surgery for…